Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ensysce Biosciences Inc
(NQ:
ENSC
)
0.3678
-0.0122 (-3.21%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Aug 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ensysce Biosciences Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Ensysce Biosciences Announces Completion of Clinical Portion of Human Abuse Potential Trial PF614-103
August 23, 2022
Via
ACCESSWIRE
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
August 19, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
Via
Benzinga
Ensysce Biosciences Releases Updated Investor Presentation Ahead of Corporate Update Call
August 17, 2022
Via
ACCESSWIRE
Ensysce Biosciences Provides Business Update and Reports Second Quarter 2022 Financial Results
August 11, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
August 18, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
August 18, 2022
It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving!
Via
InvestorPlace
Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket
August 11, 2022
Gainers
Via
Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
August 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
Via
Benzinga
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session
August 11, 2022
Gainers Timber Pharmaceuticals, Inc. (NYSE: TMBR) shares rose 63.8% to $0.1769. Timber Pharmaceuticals recently announced closing of $8.0 million public offering.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
August 11, 2022
Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 09, 2022
Via
Benzinga
Ensysce Biosciences Announces Completion of $8 Million Convertible Note Financing
August 09, 2022
Via
ACCESSWIRE
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
July 27, 2022
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 05, 2022
On Friday, 72 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 27, 2022
Gainers
Via
Benzinga
Ensysce Biosciences Announces Positive Bioequivalence (BE) Study Data of Novel "TAAP" Opioid PF614 and Provides Timing of Corporate Update Call
July 27, 2022
Via
ACCESSWIRE
Ensysce Biosciences Announces Positive Bioequivalence (BE) Study Data of Novel "TAAP" Opioid PF614 and Provides Timing of Corporate Update Call
July 27, 2022
~ BE Study of PF614 Represents Critical Progress Toward FDA Approval ~~ Supports the 505(b)(2) Regulatory Path for Clinical Development of PF614 ~SAN DIEGO, CA / ACCESSWIRE / July 27, 2022 / Ensysce...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
July 15, 2022
Gainers
Via
Benzinga
Ensysce Biosciences Announces Initial Patients Dosed of First Human Abuse Potential Study
July 13, 2022
~ Trial Designed to Test and Confirm Nasal Opioid Manipulation ~
From
Ensysce Biosciences, Inc.
Via
AccessWire
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
July 05, 2022
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Via
Benzinga
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
July 01, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.
Via
Benzinga
Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today?
July 01, 2022
Akebia Therapeutics (AKBA) stock is taking off on Friday after the kidney treatment company revealed the return of rights for vadadustat.
Via
InvestorPlace
Why Is Ensyce Biosciences (ENSC) Stock Down 27% Today?
July 01, 2022
Ensyce Biosciences (ENSC) stock is taking a beating on Friday after the clinical-stage biotech company announced $8 million in financing.
Via
InvestorPlace
Ensysce Biosciences Secures $8 Million Convertible Note Financing
July 01, 2022
~ Additional Funding from Investor Cohort Validates Company's Mission ~
From
Ensysce Biosciences, Inc.
Via
AccessWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 01, 2022
Via
Benzinga
Akebia Therapeutics And 20 Stocks Moving Premarket
July 01, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday.
Via
Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
July 01, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...
Via
Benzinga
Ensysce Biosciences Receives Notice of Award for 4th Year of Funding for Its Multi-Pill Abuse Resistance (MPAR(TM)) Platform
June 27, 2022
SAN DIEGO, CA / ACCESSWIRE / June 27, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC) (OTC:ENSCW), a clinical-stage biotech company applying transformative chemistry to...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Reminds Shareholders to Vote At Upcoming 2022 Virtual Annual Shareholder Meeting
June 21, 2022
- Shareholder Meeting to be Held on Thursday, June 23rd at 9:00 AM PT
From
Ensysce Biosciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.